by Xcellerant Ventures | Oct 5, 2021 | Portfolio Company News
Content origionally from PR Newsire: https://www.prnewswire.com/news-releases/tesis-labs-raises-20-million-in-growth-equity-capital-to-expand-clinical-capacity-301392610.html PHOENIX, Oct. 5, 2021 /PRNewswire/ — Tesis Labs, a leader in targeted genetic...
by Xcellerant Ventures | Aug 10, 2021 | Portfolio Company News
Origionally on Business Wire: https://www.businesswire.com/news/home/20210810005333/en/Tesis-Labs-and-Personal-Genome-Diagnostics-Announce-Collaboration-to-Advance-Cancer-Profiling-and-Treatment BALTIMORE & HOUSTON–(BUSINESS WIRE)–Tesis Labs, a...
by Xcellerant Ventures | Apr 7, 2021 | Portfolio Company News
You can view this article at:...
by Xcellerant Ventures | Mar 31, 2021 | Portfolio Company News
This article can be found at: https://www.natera.com/company/news/natera-and-tesis-labs-announce-strategic-collaboration-on-prenatal-genetic-testing-2/
